Here we provide proof of concept that non‐BRAF mutated SCC of the thyroid may develop from preexisting PTC, involving homozygous inactivation of several tumor suppressor genes, including KEAP1, which has previously been reported to be oncogenic in lung adenocarcinoma [6] and lung SCC [7]. The gene discussed is BRAF; the disease is neoplasm.